Showing results (321-330 of 369) with videos related to
Sort By:
Pageof 37
The New England Journal of Medicine|June 3, 2014
Enzalutamide in metastatic prostate cancer before chemotherapyTomasz M Beer, Andrew J Armstrong, Dana E Rathkopf, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.JCO Precision Oncology|October 5, 2020
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate CancerDavid R Wise, Jeffrey A Schneider, Joshua Armenia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy ResistanceHimisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.The New England Journal of Medicine|May 27, 2011
Abiraterone and increased survival in metastatic prostate cancerJohann S de Bono, Christopher J Logothetis, Arturo Molina, et al.The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2018
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter StudyHebert Alberto Vargas, Gem M Kramer, Andrew M Scott, et al.Pageof 37